Inhibitor Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Inhibitor Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2023.
  • Inhibitor Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$502K, a 23.4% increase year-over-year.
  • Inhibitor Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$3.02M, a 127% decline year-over-year.
  • Inhibitor Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.03M, a 125% decline from 2022.
  • Inhibitor Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $12.1M.
  • Inhibitor Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$299K, a 71.8% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3.03M -$15.1M -125% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $12.1M +$12.4M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 -$299K +$759K +71.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$1.06M +$1.68M +61.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$2.73M +$1.82M +39.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-26
2018 -$4.55M +$551K +10.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 -$5.1M +$1.9M +27.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 -$7M -$3.05M -77.2% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-16
2015 -$3.95M +$25.7K +0.65% Jan 1, 2015 Dec 31, 2015 10-K 2017-02-17
2014 -$3.98M -$2.14M -117% Jan 1, 2014 Dec 31, 2014 10-K 2016-02-01
2013 -$1.84M -$2.02M -1085% Jan 1, 2013 Dec 31, 2013 10-K 2015-02-13
2012 $186K Jan 1, 2012 Dec 31, 2012 10-K 2014-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.